Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
about
Cryo-electron tomographic structure of an immunodeficiency virus envelope complex in situNeutralizing and non-neutralizing monoclonal antibodies against dengue virus E protein derived from a naturally infected patientAutologous neutralizing antibodies to the transmitted/founder viruses emerge late after simian immunodeficiency virus SIVmac251 infection of rhesus monkeysAntibodies with high avidity to the gp120 envelope protein in protection from simian immunodeficiency virus SIV(mac251) acquisition in an immunization regimen that mimics the RV-144 Thai trialVirion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.Kinetic rates of antibody binding correlate with neutralization sensitivity of variant simian immunodeficiency virus strainsIdentification of two N-linked glycosylation sites within the core of the simian immunodeficiency virus glycoprotein whose removal enhances sensitivity to soluble CD4.Three-dimensional structures of soluble CD4-bound states of trimeric simian immunodeficiency virus envelope glycoproteins determined by using cryo-electron tomographyFundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages.Live simian immunodeficiency virus vaccine correlate of protection: immune complex-inhibitory Fc receptor interactions that reduce target cell availabilityLive simian immunodeficiency virus vaccine correlate of protection: local antibody production and concentration on the path of virus entry.Characterization of SIV in the oral cavity and in vitro inhibition of SIV by rhesus macaque salivaMechanistic study of broadly neutralizing human monoclonal antibodies against dengue virus that target the fusion loop.Diversity of envelope genes from an uncloned stock of SIVmac251.Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells.Systematic analysis of intracellular trafficking motifs located within the cytoplasmic domain of simian immunodeficiency virus glycoprotein gp41Removal of N-linked glycosylation sites in the V1 region of simian immunodeficiency virus gp120 results in redirection of B-cell responses to V3.Characterization and Implementation of a Diverse Simian Immunodeficiency Virus SIVsm Envelope Panel in the Assessment of Neutralizing Antibody Breadth Elicited in Rhesus Macaques by Multimodal Vaccines Expressing the SIVmac239 Envelope.A rapid progressor-specific variant clone of simian immunodeficiency virus replicates efficiently in vivo only in the absence of immune responses.Induction of antibody-mediated neutralization in SIVmac239 by a naturally acquired V3 mutation.Targeted Isolation of Antibodies Directed against Major Sites of SIV Env Vulnerability.Dynamic evolution of antibody populations in a rhesus macaque infected with attenuated simian immunodeficiency virus identified by surface plasmon resonance.Analysis of SIVmac Envelope-Specific Antibodies Selected Through Phage Display.Breakthrough Virus Neutralization Resistance as a Correlate of Protection in a Nonhuman Primate Heterologous Simian Immunodeficiency Virus Vaccine Challenge Study.A novel assay for antibody-dependent cell-mediated cytotoxicity against HIV-1- or SIV-infected cells reveals incomplete overlap with antibodies measured by neutralization and binding assaysAntigenic conservation and immunogenicity of the HIV coreceptor binding siteDissecting the humoral immune response to simian immunodeficiency virus: mechanisms of antibody-mediated virus neutralization.Conformational epitope consisting of the V3 and V4 loops as a target for potent and broad neutralization of simian immunodeficiency viruses.Heterogeneity in neutralization sensitivities of viruses comprising the simian immunodeficiency virus SIVsmE660 isolate and vaccine challenge stock.Relationship of HIV-1 and SIV envelope glycoprotein trimer occupation and neutralizationDerivation and Characterization of a CD4-Independent, Non-CD4-Tropic Simian Immunodeficiency Virus.Potent antibody-mediated neutralization and evolution of antigenic escape variants of simian immunodeficiency virus strain SIVmac239 in vivo.Importance of the V1/V2 loop region of simian-human immunodeficiency virus envelope glycoprotein gp120 in determining the strain specificity of the neutralizing antibody response.A single amino acid change and truncated TM are sufficient for simian immunodeficiency virus to enter cells using CCR5 in a CD4-independent pathway.Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.How to assess the binding strength of antibodies elicited by vaccination against HIV and other viruses.Broad and potent neutralizing antibody responses elicited in natural HIV-2 infection.Flow cytometry based identification of simian immunodeficiency virus Env-specific B lymphocytes.Assorted mutations in the envelope gene of simian immunodeficiency virus lead to loss of neutralization resistance against antibodies representing a broad spectrum of specificities.
P2860
Q21090535-3C18C2B1-DCB3-4B95-85F2-F10B84EFFE0EQ27490987-FE33008F-CA2B-4C34-9DB1-E6CF59DEA471Q28751926-E9B8113F-7A49-41A3-AED2-DD934347B284Q30532861-2B2CAF8D-AE78-4DF0-80B1-09DBDB81A782Q33984296-380D216B-8C6D-4D1C-A783-3049351D6E98Q33984358-118455A7-73E0-42AA-97B3-F406CDFB4CBAQ33984371-4A0DDE4A-E3AC-4169-8F08-77C3FBD00502Q34027126-BFA98800-2820-44D3-A6F0-BFCCD0E32FB5Q34120130-ED0B4746-318C-410D-969B-6038E201206AQ34146496-663A1643-6BDD-4D25-A265-BA21A10FD1CCQ34146728-7853F3DE-7BA6-464E-9FEF-1677E929D49DQ34213868-1BB652EB-852C-46A1-9007-B28B772EE3A5Q34306877-BAE04F0C-74D5-49F6-B9DB-5E9FF28843BDQ34315382-03CE1057-4E29-465E-9FBB-169E19548312Q34434854-D3EA0AA4-2215-4B25-A0F6-158235599EFDQ35024276-AABBA022-AF14-4E2E-B2CB-3650819C4C13Q35494155-E20C41F9-0304-44EC-9999-D86F38F96DD9Q35542887-FB30ACAA-433D-4DDA-BA07-F9A872DF5072Q35914362-2B88D7C0-048C-43A5-9CAC-623817967460Q35947881-7A2C529F-378A-41FB-AB6E-90EC3AA1361EQ35955770-138ED0A9-737D-4EB0-9D70-37CB97708789Q35985519-D1214730-3345-4C19-86B6-EDC6877B6C14Q35992786-0AE7E3C6-B1E5-4BA2-823C-8DC1CF5DFF4DQ36246070-558B1B31-9045-4FB2-A87C-3821C65A40F8Q36334371-B539594C-E8D8-40C4-8855-E5823B1F53E3Q36363866-E59AFA8D-CC5D-4B87-B896-814298E16828Q36403587-63A3BF16-1AD0-46F6-80CD-305689193072Q36751578-286148F4-DF6F-43D7-8514-2E56BE4BFE06Q36827328-5341E977-ADB7-477E-80B4-6597CC2092A0Q36827377-34C8006B-E74C-49A5-B117-EB133662D499Q36837815-D0D55125-4D9E-4B3A-AFAB-3A1EFAAD2554Q36878906-EC184D9F-B34B-4355-A845-466B51886475Q36898925-93DF4AC8-A67F-426E-B56C-EB53AF17D329Q36949880-8A8EC258-5861-4518-9F2E-B06DB80F87A3Q37177226-3AA47FFC-0B5D-441E-BB44-084D574ED5EAQ38161994-AE857096-C4C9-48F4-95CC-E42AFA62F99EQ38618790-6B4D931F-E639-460C-A4FE-77E825A13E85Q39451862-FD9F7CF0-256E-4232-98CE-1CC0464C945BQ39521335-D9F59EE1-0034-448C-8A2C-6EEFB91D7CE0Q39996517-9DF834C1-F6D8-4B7D-ADEB-CF75E27CF9F9
P2860
Characterization of neutralization epitopes of simian immunodeficiency virus (SIV) recognized by rhesus monoclonal antibodies derived from monkeys infected with an attenuated SIV strain.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Characterization of neutraliza ...... with an attenuated SIV strain.
@en
type
label
Characterization of neutraliza ...... with an attenuated SIV strain.
@en
prefLabel
Characterization of neutraliza ...... with an attenuated SIV strain.
@en
P2093
P356
P1433
P1476
Characterization of neutraliza ...... with an attenuated SIV strain.
@en
P2093
D H Elliott
J E Clements
J E Robinson
J L Rowles
M Murphey-Corb
P356
10.1006/VIRO.2001.1144
P407
P577
2001-11-01T00:00:00Z